Cargando…

Overweight: Is It a Prognostic Factor in Women with Triple-Negative Breast Cancer?

BACKGROUND: Obesity is associated with poor outcomes in patients with breast cancer expressing hormone receptors, but this association is not well established for triple-negative breast cancer. In this study, we investigated the influence of body mass index (BMI) in triple-negative breast cancer out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jarroudi, Ouissam Al, Abda, Naima, Seddik, Youssef, Brahmi, Sami Aziz, Afqir, Said
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373825/ https://www.ncbi.nlm.nih.gov/pubmed/28669161 http://dx.doi.org/10.22034/APJCP.2017.18.6.1519

Ejemplares similares

Métastase vésicale d'un adénocarcinome gastrique en bague à chaton
por: Seddik, Youssef, et al.
Publicado: (2014)

Triple Negative Breast Cancer at the University Hospital Mohammed VI – Oujda
por: Al jarroudi, O, et al.
Publicado: (2017)

Unusual Metastasis From Breast Cancer: Case Report
por: Jaouani, Laila, et al.
Publicado: (2021)

Nottingham Prognostic Index is an Applicable Prognostic Tool in Non-Metastatic Triple-Negative Breast Cancer
por: jarroudi, O Al, et al.
Publicado: (2019)

Undifferentiated Sarcoma: A Rare Tumor of the Prostate
por: Jaouani, Laila, et al.
Publicado: (2023)

Primary squamous cell carcinoma of the breast: a case report and review of literature
por: Seddik, Youssef, et al.
Publicado: (2015)

An Extranodal Site of Diffuse Large B-cell Lymphoma Presenting as Ovarian Cancer
por: Jaouani, Laila, et al.
Publicado: (2023)

Unusual Synchronous Colonic Metastasis of Ovarian Cancer
por: Jaouani, Laila, et al.
Publicado: (2023)

Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
por: El Bairi, Khalid, et al.
Publicado: (2021)

La problématique du coût des nouvelles thérapeutiques en oncologie: qu'en-est-il du Maroc?
por: Brahmi, Sami Aziz, et al.
Publicado: (2016)

Pneumopathie interstitielle aiguë fatale sous docetaxel: à propos d'un cas et revue de la littérature
por: Brahmi, Sami Aziz, et al.
Publicado: (2016)

Aménorrhée chimio induite chez une population marocaine: à propos d'une cohorte retrospective
por: Brahmi, Sami Aziz, et al.
Publicado: (2016)

L’oncologie médicale, nouvelle spécialité en Afrique?
por: Brahmi, Sami Aziz, et al.
Publicado: (2017)

Ovarian cancer in Morocco: Time to act is now
por: El Bairi, Khalid, et al.
Publicado: (2021)

Tracing ovarian cancer research in Morocco: A bibliometric analysis
por: El Bairi, Khalid, et al.
Publicado: (2021)

Practical Tools and Guidelines for Young Oncologists From Resource-Limited Settings to Publish Excellence and Advance Their Career
por: El Bairi, Khalid, et al.
Publicado: (2021)

Bevacizumab in metastatic colorectal cancer in a real-life setting – toxicity profile, survival outcomes, and impact of tumor sidedness
por: Chibani, Hind, et al.
Publicado: (2022)

Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases
por: Al Jarroudi, Ouissam, et al.
Publicado: (2020)

An unusual presentation of ovarian carcinoma with supraclavicular lymph node and colorectal metastases leading to spontaneous rectovaginal fistula
por: Kharmach, Ikram, et al.
Publicado: (2023)

Serum procalcitonin as a tumor marker in lung adenocarcinoma with ovarian metastasis: a case report
por: Omari, Mouhsine, et al.
Publicado: (2023)

Cutaneous metastasis to the face from lung adenocarcinoma
por: Brahmi, Sami Aziz, et al.
Publicado: (2016)

Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
por: Al jarroudi, Ouissam, et al.
Publicado: (2021)

Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women
por: Hao, Shuang, et al.
Publicado: (2015)

Cancer du poumon au Maroc Oriental: où en sommes-nous?
por: Belmokhtar, Karam Yahya, et al.
Publicado: (2019)

A Report of a Rare Case of an Advanced Adult Granulosa Cell Tumor Initially Diagnosed as Primary Ovarian Melanoma
por: Chacha, Rania, et al.
Publicado: (2020)

Triple negative breast carcinoma is a prognostic factor in Taiwanese women
por: Lin, Che, et al.
Publicado: (2009)

Prevalence of Childhood Short Stature, Underweight, Overweight, and Obesity Among Primary School Children
por: Bouali, Houda, et al.
Publicado: (2021)

Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features
por: Derkaoui, Touria, et al.
Publicado: (2016)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women
por: Chen, Hong-liang, et al.
Publicado: (2016)

Prognostic values of EDNRB in triple-negative breast cancer
por: Liu, Shaoqing, et al.
Publicado: (2020)

Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022)

Lymphedema after breast cancer
por: Brahmi, Sami Aziz, et al.
Publicado: (2016)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Lymphovascular invasion as a negative prognostic factor for triple-negative breast cancer after surgery
por: Ahn, Ki Jung, et al.
Publicado: (2017)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis
por: Harborg, Sixten, et al.
Publicado: (2021)

TMPRSS4 as a Poor Prognostic Factor for Triple-Negative Breast Cancer
por: Cheng, Daye, et al.
Publicado: (2013)

MicroRNA‐493 is a prognostic factor in triple‐negative breast cancer
por: Yao, Ling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_97lri2t9lcqqv885paq8jqp610